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ABSTRACT OF THESIS
CENTER OF PRESSURE EXCURSION DURING A SINGLE LEG STANDING TEST
IN AMBULATORY CHILDREN WITH CEREBRAL PALSY
INTRODUCTION: Cerebral Palsy (CP) is the most common disabling motor disorder
found during childhood, occurring in 2.1-3.2 of every 1,000 births. Motor functionality of
children with CP is commonly compromised and is classified with a gross motor function
classification score (GMFCS) and with the gross motor function measure (GMFM).
Balance ability has typically been assessed using single leg stance test (SLST) time but
more recently, center of pressure excursion (COPE) has shown to be a more valid
measurement in populations with altered motor abilities. However, COPE has not been
used to test balance in the CP population, yet. This study aimed to determine if
relationships were present between COPE measurements, functionality measurement
scores (GMCS and GMFM) and reported fall frequency. It was hypothesized that i) larger
COPE measurements would be associated with a higher GMFCS level and lower GMFM
score, and that ii) COPE measurements would be significantly higher in children with a
high reported incidence of fall frequency. METHODS: Gross functionality was measured
using a GMFM score and GMFCS level. Balance ability was assessed using COPE
measurements on a force plate and SLST time. Fall frequency was determined by a short
questionnaire. A Pearson correlation analyzed COPE measurements vs. mean GMFM
score. A one-way ANOVA was used to compare COPE measures between GMFMCS
levels, with a Bonferroni post-hoc test. Lastly, an independent sample t-test analyzed
differences in COPE measurements and SLST time between fall frequency groups.
RESULTS: Significantly larger COPE velocities were demonstrated in children who
reported a greater number of falls in the past month and were considered high risk for
falling (p = 0.02). No relationships were demonstrated between COPE measurements and
GMFM score. GMFCS level III participants demonstrated statistically significant lower
COPE velocity compared to GMFCS level II participants (p = 0.05). There were no
significant differences in SLST between high and low risk fall groups (p = 0.07).
DISCUSSION: Children with higher reported fall frequencies demonstrated a 60%
increase in COPE velocity, compared to those with little to no falls. Clinical GMFM
scores did not demonstrate significant correlations to COPE measurements and may not
be an appropriate identifier for falling in children diagnosed with CP. This is the first trial
to evaluate COPE measurements and reported fall frequencies in children diagnosed with
CP. The use of a force plate to determine COPE velocity during a SLST is useful in
identifying children with CP who may be at an elevated risk for experiencing a fall.
COPE velocity was able to provide intricate quantitative data regarding fall risk that
could not be obtained during a normal SLST.
KEYWORDS: Cerebral Palsy, Center of Pressure Excursion, Biomechanics, Fall
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CHAPTER ONE: INTRODUCTION
The introduction section provides background information about cerebral palsy,
gait abnormalities in those living with cerebral palsy, balance related issues in people
living with motor disabilities and fall risks in populations with disruptions in normal
balance ability. This section also provides information on center of pressure excursion
applications and justifies the importance of the trial.
Introduction
Cerebral Palsy (CP) is the most common major disabling motor disorder found
during childhood, with a prevalence of 2.1-3.2 cases per 1,000 births (1, 2). CP is
considered an umbrella term for permanent disorders of movement and posture, which
result in activity limitations. These disorders are attributed to non-progressive
disturbances that occurred in the developing fetal or infant brain. The motor disorders of
CP are often accompanied by disturbances in sensation and secondary musculoskeletal
disorders (1). When treatments and therapies are provided to individuals who have been
diagnosed with CP, the goal normally is not to achieve typical functionality, but rather to
sustain mental, motor and social health levels (2).
Consistent with the trend seen in many populations living with disabilities, those
with CP are now experiencing a longer life expectancy, which is increasingly closer to
that seen in the typically developing (TD) population (3, 4). However, even with this
increase in life expectancy, children and young adults with CP still experience a lower
quality of life compared to TD individuals (5). In a systematic review exploring the
health challenges facing those with CP, it was found that 3 in 4 children were in some
form of physical pain, 1 in 2 children had a concurrent intellectual disability, and 1 in 4

1

had a behavioral disorder. Additionally, it was discovered that children and adults with
CP who were unable to walk experienced far greater frequencies of accompanying health
impairments (6). This clearly emphasizes the importance of being able to execute planned
movement within this population.
Approximately 70% of children with CP are eventually able to ambulate, but most
demonstrate gait patterns that differ from the gait of a typical TD child (7). Preserving
health and functional mobility in individuals with CP is of great significance in
employment, independence, and both health-related and general quality of life. Therefore,
it is critical to closely monitor the progression of gait and gross motor ability in a child
with CP through adolescence and into adult life (10). Three-dimensional gait analysis
testing provides an objective clinical assessment which has proven helpful in producing
positive surgical outcomes for children with CP, when done prior to and following a
procedure (8). Indeed, significant correlations between gait analysis and gross motor
function have been reported in children with CP (9). However, not every clinical setting
has the space or equipment to appropriately perform a comprehensive three-dimensional
gait analysis. Therefore, many clinicians instead rely on the Gross Motor Function
Measure (GMFM) to guide clinical treatment.
The GMFM is an 88-item standardized clinical assessment instrument designed to
measure gross motor function over time in children with CP. Within the GMFM test,
multiple areas of motor ability are evaluated including; standing, walking, running and
jumping. Given the large number of motor tasks that need to be performed during this
testing protocol, administration of this scoring system is time consuming. Therefore, it
would be of value for clinicians to have a more efficient method of evaluating gross
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motor ability in children with CP without sacrificing testing sensitivity. The time saved
could be spent performing interventional and therapeutic procedures that would be of
greater benefit to pediatric CP patients (11).
Recent research has shown that stability measurements are highly correlated to
gross motor function (12). Moreover, the stability testing protocols can be performed in a
much shorter time than that seen with a comprehensive three-dimensional gait analysis or
GMFM testing. Single leg standing testing (SLST) has already been utilized to evaluate
postural stability in multiple clinical populations, including children with CP (13, 14).
Although testing is commonly performed by simply measuring the duration a participant
is able to successfully stand on one leg, force plates have also been used simultaneously
to collect center of pressure excursion (COPE) data during the test. Force plates have the
advantage of being more available than a full gait analysis setup and have been shown to
be a quantitative and valid predictor for assessing impaired balance in other clinical
populations (15). Specifically, studies have demonstrated greater COPE area and COPE
velocity for individuals with impaired balance and motor abilities, compared to the TD
population (16, 17). However, this testing has not yet been performed with children
diagnosed with CP.
Another large concern for any population with impeded balance is the increased
risk of falling. This has been widely studied in high-risk fall populations including;
stroke, elderly, Parkinson’s disease, and Muscular Dystrophy (18-21). Trials have
specifically identified balance impairment during clinical testing to be an important risk
factor leading to falls (22). SLST has previously been conducted in elderly individuals
with one trial reporting that uni-pedal stance testing can be a reliable indicator for risk of
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falling in this population (23). It is crucial for clinicians to be able to identify aspects of
motor impairment and accurately determine fall factors in order to develop fall
prevention programs (24). Measurement of COPE in patients with CP could provide
objective and quantitative information pertaining to fluctuations in COM. This
information is not currently available from a short timed SLST, as seen during the
GMFM testing, and could help clinicians in assessing which children may be at a
heightened risk for experiencing a fall.
The primary goals of this study were to examine COPE measurements during a
SLST and the following: documented Gross Motor Function Classification Score
(GMFCS) level; mean GMFM score; and reported fall frequency in ambulatory children
with CP. It was hypothesized that; i) a negative relationship would be seen between
COPE measurements and a GMFM scores; ii) significant differences would be seen in
COPE measurements between GMFCS levels; iii) significant differences would be seen
in balance measurements between high and low frequency fallers. Specifically, this was
tested using two different dependent variables, COPE measurements and SLST, and it
was postulated that the high fall frequency group would demonstrate smaller COPE
values and a shorter SLST time.
If a significant relationship between COPE measurements during a SLST and
GMFM score is present, it would allow caregivers the opportunity to evaluate a patient’s
level of gross motor function without the need to perform a complete GMFM scoring
scale. This would provide more time to perform clinical treatment, as opposed to testing
and could be more beneficial to the child. Secondly, if a relationship exists between the
number of falls and COPE measurements, it would provide caregivers with
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supplementary information on children who may be at a heightened risk of falling due to
their COPE area or COPE velocity during the SLST.
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CHAPTER TWO: METHODOLOGY
The methodology section details the specific steps that were taken to conduct this
trial. It contains information regarding the research design, population of interest,
instrumentation used, data collection procedures and data analysis procedures.
Experimental Design
This trial was a clinically based, prospective, observational study. The
independent variables of the trial were; GMFCS level, GMFM score and self-reported
fall frequency. The dependent variables of interest for this trial were COPE area and
COPE velocity during a SLST.
Participants
All study screening, recruitment and enrollment was performed in the Motion
Analysis Center at Shriners Hospital for Children in Lexington, KY. Children between
the ages of 3-21 years of age that presented to the Motion Analysis Center with CP who
were ambulatory and scheduled to perform clinical testing were invited to participate.
Participants were excluded if they were; unable to self-ambulate, unable to follow simple
orders due to intellectual disabilities, had undergone a surgical procedure within the past
six months or refused to sign the consent form. Children who used assistive walking
devices were included in the trial. All participants between the ages of 12-17 years old
signed an assent form, along with their legal guardian signing the informed consent form.
Children between 3-11 years old only required inform consent to be signed by their legal
guardian. Prior to signing consent, all participants and legal guardians were presented
with a detailed description of the study protocol and given the opportunity to ask a study
investigator any questions.
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Procedures
Participants meeting inclusion criteria visited the Motion Analysis Center at
Shriners Hospital for Children (Lexington, KY) for a total of one research visit, which
was performed during their clinically scheduled gait evaluation time.
Gross Motor Function Measurement
The Gross Motor Function Measure (GMFM) is a standardized observational
clinical test that measures change in gross motor function over a period of time in
children with CP (Appendix A). GMFM scoring was completed for all participants
during the clinical visit prior to any study specific procedures. This testing comprised of
participants performing sections D (standing) and E (walking, running and jumping) that
were scored on a 0-3 scale to produce a single uni-dimensional total GMFM score. All
GMFM scoring was performed by either a trained Occupational Therapist or
Kinesiologist.
Gross Motor Function Classification Score
The Gross Motor Function Classification System (GMFCS) classifies the motor
involvement of children diagnosed with CP based on self-initiated movement,
specifically sitting and walking. GMFCS levels for each participant were included in the
past medical history portion of their clinical visit note. The GMFCS was recorded
directly from the clinical note for each participant. For the purposed of this trial, GMFCS
levels included were I-III (Appendix B) (27).
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Fall Questionnaire
All participants completed a short fall questionnaire administered by study staff.
This questionnaire included questions regarding; CP diagnosis, age, gender, dominant
leg, fall frequency within the previous 30 days and hospital visits due to recent falls.
Single Leg Standing Test
Participants were asked to stand on an AMTI OR6-5 force plate (AMTI
Corporation, Watertown, MA) and perform SLST with both legs. Participants positioned
themselves with both feet on one force plate and were then asked to stand on one leg, first
with their right foot off the ground for three trials, then their left, for up to ten seconds to
familiarize themselves with the testing protocol. If necessary, participants were allowed
to use any assisted devices he or she may own to complete the testing, though they were
encouraged to use them as little as possible. A study investigator was present during all
testing to ensure the participants were not at risk for falling.
Once familiarization was complete, participants completed three ten-second SLST
trials with each leg, starting with the right leg off the ground first, then the left as seen in
Figure 1. While the participant performed the SLST force plate data was recorded at 960
Hz. Three-dimensional marker kinematic data was collected at 240 Hz using a Motion
Analysis System with twelve Eagle digital cameras and Cortex (Version 5.50179)
software (Motion Analysis Corporation, Santa Rosa California). Reflective markers were
placed on the participants using a modified Cleveland Clinic marker set, totaling 40
reflective markers (Appendix C). Kinematic data was then used in concert with force
plate data to define the three phases of the SLST. If the participant was unable to
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complete a trial for the full ten seconds each, he or she was informed to stand on one leg
for as long as possible.
Data Processing
All marker trajectory data were collected and tracked using Cortex (Version
5.50179) software (Motion Analysis Corporation, Santa Rosa California) and processed
using Visual 3-D (Version 5.0123) software (C-Motion Inc., Germantown, MD). Center
of pressure data for all SLST trials were exported and divided into three phases using a
combination of kinetic COP data and kinematic positional data (Appendix D). These
three phases were: stance initiation, single limb support and stance recovery. Only single
limb stance phase data was used for subsequent COPE calculations. The longest SLST
for each limb was selected and then used to calculate COPE area (m2) and COPE average
velocity (m/s) via the Zumbrunn et al. (2011) method (Appendix D). The values for both
limbs were then averaged to create one combined score for COPE area and velocity for
each subject.
Statistical Analyses
To test the first hypothesis as to whether a relationship was present between
COPE measurements and GMFM level, Pearson correlations were performed for; COPE
area vs. mean GMFM score, and COPE velocity vs. mean GMFM score. Interpretation of
correlation coefficients (r) was set for very high (r > 0.90), high (r = 0.70 – 0.90),
moderate (r = 0.50 – 0.69), low (r = 0.30 – 0.49), and negligible (r = 0.00 – 0.29) (29). To
test the second hypothesis and investigate whether differences in COPE measurements
existed between the three GMFCS levels, a one-way analysis of variance (ANOVA) was
performed in conjunction with Bonferroni post-hoc tests. Lastly, to investigate the third

9

hypothesis as to whether differences in balance existed between high and low risk fallers,
participants were divided into two separate cohorts based on reported fall frequencies.
Specifically, the groups were defined as “low frequency” (less than or equal to five
reported falls within the last 30 days) or “high frequency” fallers (greater than five
reported falls within the last 30 days). Independent sample t-tests were used to test for
differences between the high and low frequency fallers for COPE area, COPE velocity,
and SLST time. All statistical analyses were performed using SPSS 23 statistical software
(SPSS Inc., Chicago, IL) using a significance level of p < 0.05.
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CHAPTER THREE: RESULTS
The results section presents the findings of the study, including Pearson
correlational analyses, a one-way analysis of variance (ANOVA) with Bonferroni posthoc test, and an independent sample t-test were conducted on the data collected.
Subject Demographics
A total of 47 children were screened for the trial, with 30 meeting inclusion
criteria and enrollment. None of the enrolled subjects were excluded from the trial.
Therefore, 30 participants consisting of 16 males and 14 females, of which 23 were
independently ambulatory and 7 required assistive ambulatory devices (3 crutch users
and 4 walker users) and a total of 27 diplegic CP and 3 hemiplegic CP children, were
enrolled. This study enrollment size was similar to multiple other trials that observed
COPE measurements in populations with altered postural and gait abilities and
characteristics (26). The mean subject age was 14.1 years (+/- 3.8) and mean GMFM
score 72.3 (+/- 26.4). Thirteen children were classified as GMFCS level I, 10 were
GMFCS level II and 7 GMFCS level III. The division of all participants into groups of
+/-5 reported falls created one cohort of 17 individuals (5 falls or less), referred to as the
low fall risk group and on of 13 individuals (greater than 5 falls), referred to as the high
fall risk group.
COPE Measurements and Gross Motor Function
Pearson correlational testing was performed between mean GMFM score and
COPE measurements. No significant correlations where found between mean GMFM
score and COPE area (r = 0.33, p = 0.07) or mean GMFM score and COPE velocity (r =
0.19, p = 0.32). The one-way ANOVA analysis demonstrated a significant difference in
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COPE velocity values between GMFCS levels (p = 0.05). A Bonferroni post hoc test
revealed that GMFCS level III participants demonstrated statistically significant lower
COPE velocity compared to GMFCS level II participants (p = 0.05) (Table 1). No
significant differences in COPE velocity were found between GMFCS levels I and II (p =
0.40) or levels 1 and 3 (p = 0.59). There were no significant differences in COPE area
between any of the GMFCS levels.

COPE Measurements and Reported Fall Frequency
T-tests were performed between COPE measurements and fall risk cohort,
demonstrating a significant difference in COPE velocity between the high and low groups
(p = 0.02) (Figure 2). There were no significant differences (p = 0.73) in COPE area
between the high and low fall risk cohorts.
Single Limb Support Stance Time and Reported Fall Frequency
Finally, a t-test was performed between fall risk cohort and single-limb support
stance time during the SLST. No significant differences (p = 0.07) in single limb support
stance time was seen between the two fall risk cohorts (Figure 3).
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CHAPTER FOUR: DISCUSSION
The discussion section interprets the results that were reported in chapter three. It
also includes a discussion of the potential limitations of the study. The discussion aims to
contribute new knowledge to the topic in question.
Discussion
The primary aims of this trial were to investigate relationships between COPE
measurements during a SLST, GMFM score, GMFCS level and reported fall frequency in
ambulatory children with CP. To our knowledge, this is the first trial to evaluate these
measurements for children diagnosed with CP who walk independently or with an
assistive device.
Consistent with our third hypothesis, significant differences were found in mean
COPE velocity between the two fall risk cohorts. Overall, children diagnosed with CP
experience greater difficulty maintaining their balance and have been shown to
demonstrate greater postural sway than TD children (31). Consistent with the findings of
previous research using individuals with ACL injuries, chronic ankle instability and low
back pain, the present study indicated that COPE velocity was higher in individuals with
impeded balance (32). The use of gross motor function measures such as GMFM and
GMFCS were expected to be to be related to COPE measurements in this study, but this
was not the case. The heterogeneous nature of CP generates varying physical impairment
levels at numerous body structures. The location of spasticity, contracture or weakness
can have a significant influence on balance and this may not be reflected by the GMFCS
level and/or GMFM score. Given this inability to differentiate impairment location by
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uni-dimensional gross motor function score, it is not surprising that COPE measurements
were not correlated to GMFCS level and GMFM score in this population.
The poor relationship of the COPE measurements with GMFCS level and GMFM
score, suggest that these objective gross function measurement methods are not a valid
form of evaluating risk of fall in children with CP. Since previous research has
demonstrated that COPE area and COPE velocity are significantly correlated to balance
performance in children with altered balance abilities, these measurements may be a
more valid method to evaluate the risk for falls in children with CP (17). In this trial,
COPE area measures were not different between the high and low frequency fall groups.
This may be due to the selected age range of the population used for this trial, which was
3-21 years of age. In a study done examining the variation in postural sway in TD
children ages 8-12 years of age, it was discovered that significant differences exist in
sway magnitude between children above and below 10 years of age (33). With this
information, it is likely that the wide pediatric age range enrollment window may have
impacted the COPE measurement results of the SLST. A post hoc analysis displayed a
low negative correlation (r = - 0.46, p = 0.01) between age and COPE velocity. No
significant correlations were found between age and COPE area. The variation in foot
size from the youngest to oldest children enrolled in this trial, likely had an impact on the
COPE area calculations. In this study, foot size was not accounted for or normalized
during data analysis and it is possible that larger subjects have the potential to produce
greater COPE areas, regardless of gross motor ability. Previous research has also failed to
account for this variation, however most studies work to avoid this issue by defining
smaller enrollment age groups during testing and analysis (17, 31). A smaller enrollment
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age window would reduce the large variation in foot size within the subject population.
Future studies should consider this extraneous variable during study design.
Additionally, a significant difference in COPE velocity between GMFCS level II
and GMFCS level III participants was demonstrated during the SLST. The mean COPE
velocity values in the GMFCS level III group were significantly lower than those in
GMFCS II, which was opposite to the initial hypothesis. This finding is likely due to the
inclusion of ambulatory children who used assistive walking devices into the trial and
during testing. The findings in this study suggest that further research done evaluating
COPE measurements should aim to cohort individuals based on their use of assistive
walking technologies.
A 60% increase in mean COPE velocity was seen in the high fall risk group,
compared to the low risk group. This increase in COPE velocity was similar to the
difference in COPE velocity reported between congenital talipes equinovarus and TD
children by Zumbrunn et al. (2011). Additionally, similar increases in magnitude of
COPE velocity during a SLST were found in a study comparing postural control in
individuals with and without chronic ankle instability (30). Although differences in
COPE velocity were reported between the high and low frequency fallers in the present
study, SLST times were not significantly different between the two groups. The greater
ability of the COPE velocity to discriminate between high and low frequency fallers
highlights the importance and clinical significance these measurements.
It is worth noting that many clinical settings may not have the ability to perform
strain gage force plate based COPE measurements at their respective facilities, due to the
high cost of these instruments. Recent research has identified the Nintendo Wii Balance
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Board as an affordable and accurate substitute for determining COPE measurements
during a SLST (34). This may present a greater number of clinicians with the ability to
accurately evaluate COPE area and COPE velocity, in order to identify individuals at an
elevated risk for experiencing a fall.
Limitations and Recommendations for Future Research
Several limitations should be noted in this trial. Firstly, this trial included all
children with CP who were ambulatory with or without a walking device, and included
the walking device during data collection, if necessary. This was done in an effort to
determine if COPE testing would prove valid for all ambulatory children with CP,
regardless of ambulatory method. The stability provided by the walking devices during
testing would likely have influenced the COPE measurements and future studies should
design recruitment procedures to compensate for this variable.
Secondly, children with both hemiplegic and diplegic CP diagnoses were enrolled
into this trial. This was done in an effort to evaluate the validity of COPE measurements
in all ambulatory children with CP. No statistically significant differences in COPE area
or COPE velocity were present between the subjects diagnosed with hemiplegia or
diplegia (data not presented). However, it is possible that large intra-participant
differences did exist between dominant and non-dominant legs in individuals with
hemiplegic CP. Future research may benefit from only including one of these populations
and not a combination of both.
Additionally, the calculation of COPE area relied on the four most extreme X, Y
coordinates in each direction. Thus, there is a risk of an outlier data point substantially
influencing the final COPE area. Finally, differences in SLST balance abilities within the
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pediatric population for children aged 3-21 years may differ based on sensorimotor
development. Future research my benefit from the design of a smaller inclusive age
range.
Conclusion
The results of the study demonstrate that using a force plate to measure COPE
velocity during a SLST in ambulatory children diagnosed with CP, can assist in
identifying individuals who fall more frequently. These findings were compared to a
simple timed SLST, which was unable to separate children who were at a low and high
risk for fall. Additionally, the absence of significant relationships between COPE
measurements and gross motor function measures (GMFM score and GMFCS level)
within this population suggest that these measures may not be appropriate indicators for
identifying children with CP who may be at risk for experiencing a fall.
The diversity in clinical appearance of CP presents clinicians with the ongoing
challenge of how to best prescribe therapies to combat the risk for decline in gross motor
ability. With balance and fall frequency being significant determinants of quality of life
and activity inclusion in those diagnosed with CP, it is crucial that clinicians have access
to the tools necessary to accurately evaluate these quantitative variables. The use of force
plates to calculate COPE velocity has demonstrated its value in being one of these tools.

18

Appendix A: Gross Motor Function Measure Sections D & E

(35)

19

Appendix B: Gross Motor Function Classification Score

(27)
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Appendix C: Marker Set

Modified Cleveland Clinic Marker Set
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Appendix D: Center of Pressure Excursion Calculations
Each participant completed SLST three times on a strain gage force plate with
each leg, totaling six trials collected. Tracked kinematic marker data and kinetic data in
Cortex (Version 5.50179) software (Motion Analysis Corporation, Santa Rosa California)
was exported to Visual 3-D (Version 5.0123) software (C-Motion Inc., Germantown,
MD) and divided into three phases; stance initiation, single-limb stance and stance
recovery. Phases were determined using a combination of kinetic COP and kinematic
data in Visual 3-D. The events used to determine these phases were; foot off,
contralateral foot down and termination of COP motion. The beginning of stance
initiation was defined by the first mediolateral shift of motion of the COP from a static
position paired with the kinematic demonstration of contralateral movement in the
direction opposite to the side of the of the body that would be performing the stance
position for the SLST. The stance initiation phase terminated, and single-limb stance
began, when both kinetic COP data and kinematic activity demonstrated the the transition
from a double to single-limb support stance via foot off. The single-limb stance phase
continued until both kinetic COP data and kinematic activity confirmed the presence of a
double-limb support stance at foot down. Lastly, stance recovery began at the initiation of
a double-limb support and ended when kinetic COP data and kinematic activity
terminated, at stance termination. Two-dimensional X, Y coordinate COPE data were
exported from the AMTI force plate (AMTI Corporation, Watertown, MA) and only
single limb stance phase data was used for COPE measurement calculations.
One SLST for each limb was selected to be analyzed for all individuals enrolled,
which was chosen based on duration, with the longest trial achieved being used. All 2-D
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X, Y coordinate COPE data were exported to Microsoft Excel where COPE area and
velocity were calculated via the method used by Zumbrunn et al. (2011):
i.

COPE area was determined by creating a rectangular area defined by the absolute
maximum and minimum X, Y coordinate data exported from Visual 3-D, as seen
in Figure 5. The equation for this calculation is: Area = (Xmax – Xmin) × (Ymax –
Ymin) expressed in m2. The COPE areas for each selected limb trial were then
averaged together and analyzed.

ii.

COPE velocity was determined by using the first central difference method.
Calculation of the resultant displacement (RD) path of the participant’s COPE,
using

X,

Y

coordinate

data

and

the

quadratic

equation:

RD

=

(𝑋#$% − 𝑋#'% )) + (𝑌#$% − 𝑌#'% )) . This RD was then divided by the change in
time to determine the resultant velocity. The mean of all velocity measurements
during the SLST was found for each selected limb trial, then averaged together to
determine mean COPE velocity expressed in m/s.
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Appendix E: Expanded Literature Review
Cerebral Palsy
Cerebral Palsy is the most common major disabling motor disorder of childhood,
as reported by the Centers for Disease Control and Prevention. The prevalence of CP has
remained somewhat constant over the last seventy years and continues to be between 1.53 cases per 1,000 births. This data is consistent throughout nearly all parts of the world
and is not directly affected by race or ethnicity (10). CP is considered an umbrella term
for permanent disorders of movement and posture causing activity limitations, which are
attributed to non-progressive disturbances that occurred in the developing fetal or infant
brain. The motor disorders of CP are often accompanied by disturbances in sensation,
perception, cognition, communication and behavior, by epilepsy, and by secondary
musculoskeletal disorders (1). CP is a heterogeneous condition with multiple causes;
multiple clinical types; multiple patterns of neuropathology on brain imaging; multiple
associated developmental pathologies, such as intellectual disability, autism, epilepsy,
and visual impairment; and more recently multiple rare pathogenic genetic variations
(36). In most epidemiological studies, males are more at risk of CP than females: 1.3:1
(37).
Preserving health and mobility in adults with CP is of great significance in
employment, independence, and both health-related and general quality of life (10). In
previous decades, orthopedic surgery was the most popular treatment methodology of all
interventions directed toward movement normalization. However, today localized antispasticity medications such as botulinum toxin (Botox) and clinical motor learning
interventions have become more popular (38). Physical therapy techniques are highly
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utilized in the pediatric CP population with the goal being motor control maintenance and
a heightened functionality into early adulthood. Evidence suggests that physical therapy
methods, such as massage, stretching, treadmill exercise and balance training, have
significant correlations to positive functional outcomes for children with CP (11). As the
mean lifespan of individuals with CP approaches that of the typically developing
population, it is critical to provide non-invasive clinical interventions that increase quality
of life and lower the risk for future impairment (3). When children with CP have been
identified as having poor balance and postural control, therapy based training protocols
have demonstrated improvements in these areas (39).
High Risk Fall Populations
Research performed evaluating reported fall frequency in individuals with
decreased motor function, and its relation to quality of life, has been done in numerous
populations. These populations include and are not limited to; elderly, traumatic brain
injury, stroke, multiple sclerosis and Parkinson’s Disease populations. The data shows
overwhelming evidence that an increased fall frequency, or fear of falling, is correlated to
a lower quality of life (40-43). In a trial done with individuals diagnosed with
Parkinson’s Disease, the fear of falling had a greater detrimental effect on quality of life
than the actual act of falling itself (44).
Little research has been performed observing fall frequencies within the CP
population, and even less when it comes to the pediatric cohort. In a study done with
community dwelling adults living with CP, poor balance was discovered during clinical
balance testing, which increased from early adulthood onto later life (45). However, the
balance obstacles facing individuals with CP start before early adulthood and can
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manifest as barriers in a child’s life. Research has shown that children with physical
disabilities benefit from physical activity, which has been correlated to improved
functional independence, social integration and emotional and social well being (46). For
children who reported experiencing significant limitations in balance ability, or fear of
falling, it was shown to not be directly explained by their self-reported walking
deterioration. This raises the question whether gait analyses or questionnaires are an
appropriate test for predicting balance ability and risk of fall in children with CP.
Center of Pressure Excursion
Center of pressure is defined as the point at which the pressure of the body under
the foot, or feet, centralizes as one single coordinate. Sway of the body, or static
posturography, can be measured by calculating the deviations in this single pressure point
to generating a total area, referred to as COPE area or a velocity, referred to as COPE
velocity, on a force plate (26, 47). These measures have been used in numerous
populations to quantitatively evaluate postural stability and balance during single and
double limb support testing protocols. Data obtained from these calculations have shown
correlations to variables such as; pain experienced during testing, chronic lower extremity
instability and ability to maintain posture (30, 48, 49).
COPE testing has been performed in the pediatric CP population, using a double
limb stance protocol to test differences in eye open and eye closed excursion values
compared to TD children (50). Postural sway, as determined by COPE area, was found to
be greater in children with CP, compared to TD. Single leg stance based protocols have
also been used in trials to determine COPE. In a study evaluating children with
congenital equinovarus, it was found that COPE measurements, specifically COPE
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velocity, were correlated to balance (17). These results suggest that the use of a single leg
stance test to determine COPE measurements in children with orthopedic impairments
may be useful in determining balance ability. The single leg stance testing protocol to
determine COPE measurements has not yet been performed in the pediatric CP
population.
Gross Motor Function Measure
For approximately three decades the Gross Motor Function Measure (GMFM) has
been administered to children with neurologically based disabilities, such as CP, and used
as an outcome measure to track rehabilitation techniques (51). There are two versions of
the GMFM test, the GMFM-88 and more recent GMFM-66, which are both standardized
clinical tools designed to measure gross motor function over time in children with CP
(52). Both tests are approved for use in children ages 5 months to 16 years of age. Within
the GMFM test, multiple areas of motor ability are evaluated, including; standing,
walking running and jumping. Standing function testing is included in the GMFM-D
section and walking, running and jumping within the GMFM-E section.
The GMFM-88 includes 88 items of measure to calculate a uni-dimensional
determination of gross motor ability. Each item is measured on a scale of 0-3, with three
being the highest functional score attainable and zero representing an inability to initiate
the measure of the specified test. This test has shown to be reliable and valid in testing
the level of gross motor ability in children with CP (53). Interestingly, GMFM scoring
systems have shown to be less sensitive in children who are either highly impaired
(GMFCS levels IV-V) or only slightly impaired (GMFCS level I). It is recommended that
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clinicians use the GMFM, in conjunction with other outcome measures, to determine the
comprehensive ability of a child with CP (54).
Summary
In conclusion, children with CP face tremendous obstacles in a plethora of daily
functional motor activities, including the ability to maintain balance. These challenges
are not unlike those encountered by other populations who live with neuromuscular
disabilities, which present a heightened risk for falls. Falling, or the fear of falling, has
shown to have a significantly negative impact on quality of life and steps should be taken
to diminish this risk whenever possible. COPE measurements have been used in many
populations living with decreased balance abilities and could be a viable option for
clinicians to use in the pediatric CP population, as well. If validated, COPE
measurements could be used to identify those children at an elevated risk for
experiencing a fall. This data could provide clinicians with the information necessary to
incorporate supplemental balance improvement therapies, which have proven to increase
balance abilities and lower fall frequency. This decrease in falls could lead to a higher
quality of life, greater functional independence and social involvement.
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